Skip to main content
. 2020 Nov 11;3(3):311–317. doi: 10.1016/j.cjco.2020.11.003

Table 3.

Characteristics of patients with NSTEMI according to SARS-CoV-2 infection status

All (N = 121) SARS-CoV-2 (n = 9) Non-SARS-CoV-2 (n = 112) P
Age, years 66.8 ± 13.9 61.6 ± 14.8 67.2 ± 13.8 0.24
Male sex 84 (69) 7 (78) 77 (69) 0.58
Cardiac arrest at presentation 3 (2.5) 1 (11.1) 2 (1.8) 0.08
Nonobstructive coronary arteries 16 (13.2) 1 (11.1) 15 (13.4) 0.85
Infarct related artery 0.61
 Left main 6 (5.7) 0 (0) 6 (6.2)
 Left anterior descending 44 (41.9) 5 (62.5) 39 (40.2)
 Left circumflex 24 (22.8) 1 (12.5) 23 (23.7)
 Right coronary artery 31 (29.5) 2 (25) 29 (29.9)
Type of culprit lesion 0.021
 Acute occlusion 19 (18) 4 (50) 15 (15.5)
 Stenosis > 50% 81 (77) 3 (37.5) 78 (80.4)
 Stenosis < 50% 5 (4.7) 1 (12.5) 4 (4.1)
Coronary anatomy 0.77
 Single-vessel disease 31 (29.5) 2 (25) 29 (29.9)
 Multivessel disease 37 (35.2) 6 (75) 69 (71.1)
Procedural aspects
 Thromboaspiration 4 (3.8) 0 (0) 4 (4.1) 0.56
 Stent PCI 89 (84.8) 7 (87.5) 80 (82.5) 0.72
 Any PCI (balloon or stent) 92 (87.6) 7 (87.5) 83 (85.6) 0.88
 Anti-GP IIb/IIIa use 5 (4.7) 2 (25) 3 (3.1) 0.049
 Persistent no-reflow 4 (3.8) 1 (12.5) 3 (3.3) 0.19
Outcome (all NSTEMI patients)
 In-hospital death 5 (4.1) 0 (0) 5 (4.5) 0.52
 In-hospital cardiac arrest 8 (6.6) 3 (33.3) 5 (4.5) 0.007
 Cardiogenic shock or heart failure 16 (13.2) 2 (22.2) 14 (12.5) 0.41
 LVEF on discharge, % 52 ± 11 48 ± 10 53 ± 11 0.24
 Median peak Hs troponin, ng/L 443 [131-1269] 605 [311-2631] 441 [120-1256] 0.26
 Median C-reactive protein, mg/L 3.3 [2-15] 68.1 [46-115] 3.0 [2-8] < 0.001

Data are presented as n (%), mean ± SD, or mean [25%-75% quartile]. Bold values represent P < 0.05.

C-reactive protein, C-reactive protein; GP, glycoprotein; Hs, high-sensitivity; LVEF, left ventricular ejection fraction; NSTEMI, non-ST-elevation myocardial infarction; PCI, percutaneous coronary intervention.

P value is given for contingency tables.